Mainolfi Nello

CIK 00018211891 companyWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001821189

Recent Transactions

50 trades

Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-01-05−3,118→ 446,882 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-01-05$32.07/sh+3,118→ 666,195 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-31$77.95/sh−23,986→ 669,091 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-31$78.52/sh−6,014→ 663,077 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-31$2.08/sh+30,000→ 693,077 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-12-31−30,000→ 275,559 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-12-17−2,595→ 272,505 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-17$38.53/sh+2,595→ 663,077 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$2.08/sh+100,000→ 760,482 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-12-08−100,000→ 305,559 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$89.17/sh−100,000→ 660,482 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-29$59.72/sh−1,862→ 688,620 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-29$61.02/sh−24,511→ 664,109 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-29$61.46/sh−3,627→ 660,482 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-10-29−30,000→ 405,559 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-29$2.08/sh+30,000→ 690,482 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-09-16−30,000→ 435,559 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-09-16$2.08/sh+30,000→ 690,482 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-09-16$49.00/sh−30,000→ 660,482 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-03$49.00/sh−30,000→ 660,482 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-03−30,000→ 465,559 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-03$2.08/sh+30,000→ 690,482 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-03-03+365,000→ 365,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-01-10+10,000→ 495,559 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-01-10$2.08/sh+10,000→ 659,959 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-07-01$5.33/sh+18,773→ 649,959 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-07-01−18,773→ 288,456 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-06-18$2.08/sh+14,413→ 631,186 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-06-18−14,413→ 505,559 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-03-01+530,000→ 530,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-01-02−9,000→ 519,972 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-01-02$2.08/sh+9,000→ 615,570 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-11-03−2,368→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-11-03−17,632→ 528,972 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2023-11-03$2.08/sh+2,368→ 588,938 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2023-11-03$2.08/sh+17,632→ 606,570 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-08-08−12,000→ 2,368 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2023-08-08$2.08/sh+12,000→ 586,570 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-03-01+450,000→ 450,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-12-08$2.08/sh+10,000→ 573,700 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-12-08−10,000→ 18,725 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-10-17−32,056→ 14,368 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-10-17$2.08/sh+32,056→ 534,255 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-10-17−27,676→ 546,604 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-10-17$2.08/sh+27,676→ 561,931 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-05-03$2.08/sh+20,000→ 502,199 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-05-03−20,000→ 46,424 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-03-01+275,100→ 275,100 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-01-14−10,000→ 66,424 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-01-14$2.08/sh+10,000→ 482,199 total

Companies

Kymera Therapeutics, Inc.
Director, Chief Executive Officer
$KYMR

Recent Filings

Address

C/O KYMERA THERAPEUTICS, INC. 500 NORTH BEACON STREET, 4TH FLOOR

WATERTOWN, MA, 02472

View on SEC.gov